Drug intelligence / Profile preview

testosterone enanthate

Development stage
Approved
Lead developer
Halozyme
Modality
Small Molecules
Administration
Intramuscular, Subcutaneous
01

Overview

Testosterone enanthate is a synthetic derivative of the naturally occurring androgen, testosterone. It is an esterified form (enanthic acid ester) that acts as a long-lasting prodrug of testosterone, providing sustained release after intramuscular or subcutaneous injection. Testosterone enanthate functions as an agonist at the androgen receptor, mediating its effects by promoting the development and maintenance of male secondary sexual characteristics, muscle and bone growth, libido, and spermatogenesis. In men and boys, it is primarily used for replacement therapy in conditions associated with deficiency or absence of endogenous testosterone such as primary hypogonadism (testicular failure), hypogonadotropic hypogonadism (pituitary/hypothalamic injury), and delayed puberty not due to pathological disorders. In women, it may be used for advanced inoperable metastatic breast cancer that is hormone-responsive[1][2][3][5]. It has also been used in masculinizing hormone therapy for transgender men[5]. The drug was first introduced into medical use in 1954.

Brand names
DelatestrylXyostedAveedDepo-Testosterone
Other names
testosterone enantatetestosterone heptanoate
02

Targets

ESR1 (ERα)AR (Adrenergic receptors)

Beyond the preview

Go deeper on testosterone enanthate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on testosterone enanthate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call